Folate status and neural tube defects

Area of Science:

• Obstetrics and Gynecology
• Nutritional Science
• Genetics

Background:

• Periconceptional folic acid supplementation significantly reduces neural tube defects (NTDs).
• Pregnancy red cell folate levels correlate inversely with NTD risk, even in women without deficient blood folate.
• Research investigates genetic factors in folate metabolism impacting NTD prevention.

Purpose of the Study:

• To explore the role of genetic variations, specifically the MTHFR C677T variant, in NTD etiology.
• To determine if genetic factors fully explain reduced folate levels in mothers of NTD-affected infants.
• To identify key risk factors for NTDs and inform public health strategies.

Main Methods:

• Analysis of the C677T variant in the 5,10-methylenetetrahydrofolate reductase gene.
• Correlation of genotype (TT) with red cell folate status.
• Comparison of genotype prevalence in spina bifida cases and controls.
• Assessment of the variant's contribution to reduced folate levels in NTD-affected mothers.

Main Results:

• The C677T variant (TT genotype) is more prevalent in spina bifida cases and their parents.
• Homozygous individuals (TT) exhibit approximately 20% lower red cell folate levels.
• The MTHFR C677T variant does not fully explain reduced folate status in many mothers of NTD-affected infants.

Conclusions:

• Low maternal folate status is a significant risk factor for NTDs.
• Genetic variations like MTHFR C677T contribute but may not be the sole explanation for folate-related NTDs.
• Food fortification represents a potentially effective population-level strategy for NTD elimination.